Compare CHSCL & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHSCL | HLN |
|---|---|---|
| Founded | N/A | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Package Goods/Cosmetics |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 41.7B |
| IPO Year | N/A | N/A |
| Metric | CHSCL | HLN |
|---|---|---|
| Price | $25.38 | $10.14 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | ★ 9.7M |
| Earning Date | N/A | 07-31-2025 |
| Dividend Yield | N/A | ★ 1.79% |
| EPS Growth | N/A | ★ 41.64 |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $15,096,588,575.00 |
| Revenue This Year | N/A | $1.51 |
| Revenue Next Year | N/A | $4.67 |
| P/E Ratio | ★ N/A | $21.55 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | N/A | $8.71 |
| 52 Week High | N/A | $11.42 |
| Indicator | CHSCL | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 41.57 | 65.58 |
| Support Level | $25.25 | $10.05 |
| Resistance Level | $25.39 | $10.16 |
| Average True Range (ATR) | 0.09 | 0.12 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 25.19 | 94.78 |
CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.